WHO condemns global failure in vaccine supply as poor countries go wanting
3 years, 6 months ago

WHO condemns global failure in vaccine supply as poor countries go wanting

India Today  

Rich countries are opening up societies and vaccinating young people who are not at great risk from Covid-19, while the poorest countries cruelly lack doses, the World Health Organization said on Friday, condemning a global failure. The situation in Africa, where new infections and deaths jumped by nearly 40% last week compared to the previous week, is "so dangerous" as the Delta variant spreads globally, WHO director-general Tedros Adhanom Ghebreyesus said. COVAX, run jointly by the GAVI vaccine alliance and the WHO, has delivered 90 million Covid-19 vaccine doses to 132 countries since February, but has faced major supply issues since India suspended vaccine exports. "We have through COVAX this month zero doses of AstraZeneca vaccines, zero doses of SII vaccines, zero doses of J & J vaccine," said Bruce Aylward, WHO senior adviser.

Countries Doses Zero Doses Vaccines Tedros  week  variant  vaccine  global  vaccines  tedros  condemns  doses  failure  world  countries  zero  wanting  supply  covid19  poor

History of this topic

Why Americans are opting out of getting a COVID booster shot
1 month, 2 weeks ago

Why Americans are opting out of getting a COVID booster shot

Daily Mail  

A recent survey reveals that a significant number of Americans are unlikely to get a COVID-19 booster vaccine this season. Conducted by the Pew Research Center between October 21 and 27, the survey of 9,593 U.S. adults found that 60% of respondents said they would 'probably not' get an updated vaccine. A full 81% of Republicans said they probably wouldn't …

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive
5 months, 3 weeks ago

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive

Live Mint  

New Delhi: With US President Joe Biden testing positive for COVID-19 before the Presidential elections, the World Health Organisation has warned the public that Covid is still not over. WHO director-general Tedros Adhanom Ghebreyesus issued a warning, stating that vaccination rates among health professionals and the over-60s—two demographics most at risk of dying from COVID—are alarmingly falling. Globally, 9.8 million …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
7 months ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 4 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
8 months ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine
8 months, 1 week ago

Covishield: Gujarat Cong Demands Compensation, BJP Claims Heart Attacks Not Linked to Vaccine

News 18  

The opposition Congress on Wednesday alleged that the BJP government at the centre did not follow the guidelines of the World Health Organisation, and demanded that the relatives of those who died due to heart attack or similar reasons after taking the Covishield vaccine against coronavirus should be paid compensation. Doctors associated with the Gujarat BJP, however, said a study …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination
10 months, 2 weeks ago

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination

The Hindu  

One of the largest assessments of its kind, spanning 99 million people and investigating reports of adverse reactions following COVID-19 vaccination, found that instances of Guillain Barre Syndrome, myocarditis, pericarditis and cerebral venous sinus thrombosis were at least 1.5 times more than expected following inoculation with mRNA and ChadOX1 vaccines. The Global Covid Vaccine Safety Project, which made the assessment, …

With State prod, India can be world leader in vaccines
11 months, 2 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Covid-19: India reports 441 fresh JN.1 cases; active caseload declines to 3,238
11 months, 3 weeks ago

Covid-19: India reports 441 fresh JN.1 cases; active caseload declines to 3,238

Firstpost  

India has recorded 441 fresh COVID-19 infections while the number of active cases has come down to 3,238, the Union health ministry said on Saturday. The number of daily cases was in double digits till December 5 but it began to rise again amid cold weather conditions and after the emergence of a new COVID-19 variant, JN.1.After December 5, the …

Nearly 10,000 died from COVID-19 last month, fueled by holiday gatherings and new variant, WHO says
11 months, 4 weeks ago

Nearly 10,000 died from COVID-19 last month, fueled by holiday gatherings and new variant, WHO says

Associated Press  

GENEVA — The head of the U.N. health agency said Wednesday holiday gatherings and the spread of the most prominent variant globally led to increased transmission of COVID-19 last month. Tedros Adhanom Ghebreyesus said nearly 10,000 deaths were reported in December, while hospital admissions during the month jumped 42% in nearly 50 countries — mostly in Europe and the Americas …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Updated COVID vaccines will be available later this week, recommended for everyone six months and up
1 year, 3 months ago

Updated COVID vaccines will be available later this week, recommended for everyone six months and up

Salon  

A new, fourth round of COVID-19 booster shots was approved Tuesday, following the recommendation of federal health agencies, which will make the vaccines available to Americans later this week. The Centers for Disease Control and Prevention followed suit this afternoon, with CDC director Mandy Cohen recommending updated vaccination for "everyone 6 months and older to better protect you and your …

Continue COVID-19 testing to check emergence of new virus variants: WHO chief
1 year, 4 months ago

Continue COVID-19 testing to check emergence of new virus variants: WHO chief

The Hindu  

Warning that many countries aren’t testing enough and that new SARS-CoV-2 virus variants may emerge, Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, on Wednesday said that testing and being vigilant is vital in continuing the fight against COVID-19. “While COVID is now behind us and India did its best during the time, we can expect new and more …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 6 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 7 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 7 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

US to end Covid vaccination mandate for foreign travellers, federal workers on May 11
1 year, 8 months ago

US to end Covid vaccination mandate for foreign travellers, federal workers on May 11

India Today  

The United States will end its Covid-19 vaccination requirements for international travellers and federal workers on May 11, when the coronavirus public health emergency ends, the White House said on Monday. In February, the US House of Representatives voted to lift the requirement that most foreign air travellers be vaccinated against Covid-19, one of the few remaining pandemic travel restrictions …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 8 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

Serum Institute of India to produce 5mn Covishield doses in two months
1 year, 8 months ago

Serum Institute of India to produce 5mn Covishield doses in two months

Hindustan Times  

Serum Institute of India chief executive officer Adar Poonawalla, while underlining that the current strain of Covid is mild and the demand for vaccine shots is low, said his firm will produce five to six million Covishield doses in the next two to three months and same amount of stock is already available for Covovax. According to Poonawalla, SII has …

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain
1 year, 8 months ago

WATCH: SII chief Adar Poonawalla on vaccine availability, current Covid strain

Hindustan Times  

Commenting on the recent spike in Covid cases countrywide, Serum Institute of India chief executive officer Adar Poonawalla on Saturday said that the current variant of the virus is not severe and five to six million doses of Covovax are available. We will also produce the same amount of Covishield doses in the next two to three months,” news agency …

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
1 year, 8 months ago

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report

The Hindu  

Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project and published by UNICEF on April 20. UNICEF India today released the agency’s global flagship report ‘The State of the World’s Children 2023: For Every …

India among countries with highest vaccine confidence. What about its neighbours
1 year, 8 months ago

India among countries with highest vaccine confidence. What about its neighbours

Hindustan Times  

UNICEF India on Thursday released the agency's global flagship report "The State of the World's Children 2023: For Every Child, Vaccination," highlighting the significance of childhood immunisation. According to Cynthia McCaffrey, UNICEF India Representative, World's Children 2023 report highlights India as one of the countries with the highest vaccine confidence in the world, "The State of the World's Children 2023 …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

Studies show XBB.1.16 is not clinically more severe
1 year, 8 months ago

Studies show XBB.1.16 is not clinically more severe

Hindustan Times  

The XBB.1.16 sub-variant of the Omicron strain of the SARS-CoV-2 virus that causes Covid does not exhibit higher clinical severity according to preliminary results from laboratory studies being conducted in the country to know disease characteristics, according to people familiar with the matter. According to the World Health Organisation, mutations at position 478 of the SARS-CoV-2 spike protein have been …

Active COVID-19 cases in India rise to 21,179
1 year, 9 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults
1 year, 9 months ago

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Hindustan Times  

Amid rising coronavirus cases, the Serum Institute of India has written a letter to the Union health ministry seeking the inclusion of its COVID-19 vaccine Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. The letter was written by Prakash Kumar Singh, Director, Serum Institute of India on March 27, they said. …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India records over 300 new Covid cases after 97 days
1 year, 10 months ago

India records over 300 new Covid cases after 97 days

Hindustan Times  

India logged more than 300 fresh coronavirus cases after 97 days, while the active cases increased to 2,686, according to the Union health ministry data updated on Saturday. The country's infection tally stands at 4.46 crore The country saw a single-day rise of 334 new cases, while the death toll rose to 5,30,775 with three latest fatalities -- two reported …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella
1 year, 11 months ago

COVID-19: 3 lakh doses of intranasal vaccine iNCOVACC sent to hospitals, says Bharat Biotech's Krishna Ella

India TV News  

COVID-19 vaccine : Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday. "We dispatched three lakh doses of the world's first intranasal COVID-19 vaccine to some hospitals two days ago," Ella said. Establishing the UW-Madison Global One Health Centre holds great significance as …

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it
1 year, 11 months ago

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it

News 18  

Pfizer CEO Albert Bourla being quizzed at Davos by journalists about the company’s Covid-19 vaccine has triggered the BJP to take on top Congress and AAP leaders for earlier pushing for the Pfizer shot to be brought to India. But facts show that not only was the vaccine offered by Pfizer and Moderna exorbitantly priced at over $20 for each …

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

Covid-19: Active Cases in Country Dip to 2,149
1 year, 11 months ago

Covid-19: Active Cases in Country Dip to 2,149

News 18  

India logged 104 new coronavirus infections, while the active cases declined to 2,149, according to the Union Health Ministry data updated on Sunday. The active cases comprises 0.01 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.80 per cent, according to the ministry website. According to the ministry’s website, 220.17 crore doses of Covid …

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla
2 years ago

COVID-19: Covovax vaccine to get approval as booster dose in 10-15 days, says Poonawalla

Firstpost  

Pune: Chief Executive Officer of Serum Institute of India, Adar Poonawalla, has said their Covovax vaccine will get approval as a booster dose against Covid-19 in the next 10 to 15 days. Poonawalla told the media that the vaccine works very well against the Omicron variant of coronavirus. Speaking to reporters on the sidelines of an event at the Bharati …

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla
2 years ago

Covovax to get approval as booster in 10-15 days, says SII’s Adar Poonawalla

Live Mint  

As India braces for a possible rise in COVID-19 cases, a new vaccine is set to join the ranks as booster this month. Serum Institute of India's Covovax vaccine - which is effective against the Omicron strains - will get approval as a booster jab against COVID-19 in the next 10 to 15 days. All you need to know about …

No second Covid-19 booster dose required: Report
2 years ago

No second Covid-19 booster dose required: Report

Live Mint  

There is no need to take a second booster dose against Covid-19 infection, news agency ANI reported on Tuesday citing government sources. According to the data by the Union Health Ministry, a total of 220.11 crore vaccine doses have been administered in the country, of which 95.13 crore have taken the second dose while only 22.41 crore of the population …

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts
2 years ago

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts

Deccan Chronicle  

NEW DELHI: Several countries are administering a third and even fourth Covid booster shot but India, where many fully vaccinated individuals have not taken even one, is not there yet, say experts while stressing on the need for a structured and systematic response. If that infection did not trigger enough Omicron-specific immunity none of the vaccines currently available in India …

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses
2 years ago

Biological E, Bharat Biotech have stockpile of 250 million COVID vaccine doses

India TV News  

As Covid cases are increasing in the country, now focus is back on vaccination drive. According to sources- two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together have about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received. Corbevax and Covaxin stocks Biological E held 200 million doses of its …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Discover Related